PhonePe Invest
Shukra Pharmaceuticals Ltd.

Shukra Pharmaceuticals Ltd.

SHUKRAPHAR

Small CapPharmaceuticals
Shukra Pharmaceuticals Ltd.

Shukra Pharmaceuticals Ltd.

SHUKRAPHAR

Small CapPharmaceuticals

Shukra Pharmaceuticals Ltd. Share Price

68.88 +2.09 (+3.13%)

Share Price Today – Shukra Pharmaceuticals Ltd.

As of October 16, 2026, Shukra Pharmaceuticals Ltd. share price is ₹68.88. The stock opened at ₹66.79 and closed at ₹66.79 in the previous session. During the trading session, the share price moved between ₹66.78 and ₹71.73. Over the last 52 weeks, the stock has recorded a low of ₹26.30 and a high of ₹75.50. In terms of performance, the stock has delivered 98.7% returns over the past six months and 86.9% returns over the last year.

About the company

Shukra Pharmaceuticals is engaged in the manufacturing, marketing, and export of pharmaceutical formulations. The Company caters to both domestic and international markets, with a growing presence in countries such as Australia, Uganda, Kenya, the United Kingdom, Sri Lanka, Mauritius, and the Republic of Yemen.
Crisp AnalysisAnalysis

Positive momentum vs quality risks

Today's Low
66.78
Today's High
71.73
52W Low
26.30
52W High
75.50

Fundamentals

Market Cap

₹2,961Cr

EPS

₹0.50

Book Value/Share

₹2.33

P/E Ratio (TTM)

86.18

Industry P/E (TTM)

45.10

P/B Ratio

32.55

Long Term D/E

0.05

ROE

28.88%

Dividend Yield (TTM)

0.00%

Sector P/E Ratio (TTM)

39.51

Sector P/B Ratio

5.33

Shareholding Pattern

Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.

FAQs on Shukra Pharmaceuticals Ltd.

The share price of Shukra Pharmaceuticals Ltd. is ₹68.88 on NSE as of 16/10/2026, 8:23:16 pm. Share prices may change frequently due to market movements.

The market capitalisation of Shukra Pharmaceuticals Ltd. is ₹2,961Cr as of 16/10/2026, 8:23:16 pm

The current Price to Earnings (P/E) ratio of Shukra Pharmaceuticals Ltd. is 86.18 as of 16/10/2026, 8:23:16 pm

The Price to Book (P/B) ratio of Shukra Pharmaceuticals Ltd. stands at 32.56 as of 16/10/2026, 8:23:16 pm

Shukra Pharmaceuticals Ltd. reported an ROE of 28.88% for the last reported financial year on a consolidated account basis.

As of 16/10/2026, 8:23:16 pm, Shukra Pharmaceuticals Ltd.’s shareholding pattern is: promoters hold 51.00%, FIIs hold 0.00%, DIIs hold 0.10%, and public shareholders hold 48.90%.

The 52-week high of Shukra Pharmaceuticals Ltd. is ₹75.50 and the 52-week low is ₹26.30 as of 16/10/2026, 8:23:16 pm.

The earnings per share (EPS) of Shukra Pharmaceuticals Ltd. is -- for the quarter ended Sep 2026.

The stock symbol of Shukra Pharmaceuticals Ltd. is SHUKRAPHAR.

You can buy Shukra Pharmaceuticals Ltd. shares by opening a demat and trading account with PhonePe Invest and placing a buy order on NSE or BSE during market hours.

The fair value of Shukra Pharmaceuticals Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.

Overview

Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.

Outperformer

Poor Quality

High Price Fluctuation

Disclosure and Disclaimer

Earnings Per Share

Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.

Income Statement

Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.

Particulars (in Cr)Jun 2026Q/Q Change
Operating Revenue23.52+272.15%
Other Income0.54-43.16%
Total Income24.06+230.95%
Total Expenditure4.38-22.06%
EBIDT19.68+1,092.73%
Depreciation1.08+6.93%
Interest0.43+65.38%
Tax5.21+148.10%
Net Profit12.96-853.49%

Balance Sheet

A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.

Particulars (in Cr)Mar 2026
Total Current Assets83.81
Total Non-Current Assets33.63
Fixed assets33.63
Total Assets117.44
Total Current liabilities23.09
Total Non Current Liabilities4.50
Total Equity Plus Liabilities117.44
Total Shareholder Funds89.85
Total Debt to Equity6.00%

Cash Flow

Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.

Particulars (in Cr)Mar 2026
Cash from Operating Activity3.93
Cash from Financing Activities4.07
Cash from Investing Activities-14.14
Net Cash Flow-6.14

Time Period: Daily

SMA/EMA (Moving Average) Analysis

Bullish Moving Averages15

Bearish Moving Averages1

5 Day

66.80

10 Day

67.40

20 Day

62.40

30 Day

59.40

50 Day

52.20

100 Day

41.60

150 Day

39.00

200 Day

40.70

Indicators

RSI (14)

67.28

MACD (12, 26)

4.63

MACD Signal Line (9)

4.94

MFI (14)

77.02

ATR (14)

3.42

ADX (14)

55.98

ROC (21)

20.75

ROC (125)

88.85

Pivot Analysis

Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.

TypeR1R2R3PPS1S2S3
Classic0.000.000.000.000.000.000.00

Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.

Volume Analysis

Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.

Shukra Pharmaceuticals Ltd.

Shukra Pharmaceuticals Ltd.

SHUKRAPHAR

Small CapPharmaceuticals

Open Price

66.79

Previous Close

66.79

Volume

78,59,711

Average Price

69.38

Upper Circuit

80.14

Lower Circuit

53.44
Today's Low
66.78
Today's High
71.73
52W Low
26.30
52W High
75.50

Historical Performance

Momentum 4/5
NA1 Day
NA5 Days
NA1 Month
NA3 Months
NA1 Year
NA5 Years
NA10 Years
Trademarks owned by their respective owners are shown here only for ease of recall of the respective owner by public.